You are here:  Home » Research Funding » Funding News » NINDS Notes - March 2009 » 

Skip secondary menu

Funding News - Parkinson’s Disease

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

NINDS invites applications for research on the cognitive sequelae of Parkinson’s disease (PD). This announcement is made together with 3 other NIH components and is supported by 2 funding mechanisms: R01 and R21.

PD is commonly viewed as an extrapyramidal motor disorder. Therefore, a substantial amount of research has focused on understanding the neural mechanisms underlying the most apparent symptoms (tremors and slowness in the initiation of movements) and on their treatment.  PD is more than a motor disease however, it also affects thinking, reasoning, learning, processing speed, and other cognitive abilities as well as regulation of mood and affect. In addition, medications commonly used to treat PD can provoke or enhance cognitive dysfunction. The cognitive and affective changes seen in PD are less understood and studied than the motor symptoms.

Potential applicants should contact Dr. Debra Babcock, program director, Systems and Cognitive Neuroscience Cluster, NINDS; telephone: 301-496-9964; email: db390r@nih.gov; or Dr. Beth-Anne Sieber, program director, Neurodegeneration Cluster, NINDS; telephone: 301-496-5680; email:  sieberb@ninds.nih.gov. For more information visit http://grants.nih.gov/grants/guide/pa-files/PA-09-033.html or http://grants.nih.gov/grants/guide/pa-files/PA-09-034.html.